Numerate, Inc.

UEI
DYZZL3651LF3
CAGE
4THP8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
numerate.com
Founded
2007
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Numerate, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
EZH2 inhibitors as endoprosthetic device coatings that induce osteogenesis and promote implant osseointegration Grant · R43AR073051 National Insititue of Arthritis and Musculoskeletal and Skin Diseases $224,878
Peripherally restricted ??2/??-1 subunit ligands that modulate CAV channel gating as novel antiarrhythmic drugs Grant · R44HL139143 National Heart Lung and Blood Institute $0
Peripherally restricted ?2/?-1 subunit ligands that modulate CAV channel gating as novel antiarrhythmic drugs Grant · R43HL139143 National Heart Lung and Blood Institute $224,927
Base period Contract · HDTRA110C0029 Defense Threat Reduction Agency $4,903,991
Drug engineering of transglutaminase 2 inhibitors Grant · R41DK081244 National Institutes of Health $252,139

Quick answers

What is Numerate, Inc.'s UEI?

Numerate, Inc.'s Unique Entity ID (UEI) in SAM.gov is DYZZL3651LF3.

What is Numerate, Inc.'s CAGE code?

Numerate, Inc.'s CAGE code is 4THP8.

What is Numerate, Inc.'s primary NAICS code?

Numerate, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Numerate, Inc. registered in SAM.gov?

Numerate, Inc.'s SAM.gov registration expired on May 23, 2020.

What is Numerate, Inc.'s most recent federal award?

Numerate, Inc.'s most recent federal grant award is EZH2 inhibitors as endoprosthetic device coatings that induce osteogenesis and promote implant osseointegration (R43AR073051), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on September 13, 2017.

On GovTribe

See Numerate, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login